← All indications
Lymphangioleiomyomatosis
A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath (DYSPNEA).
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (1)
Phase 2 trials (11)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (18)
- Wyeth
- University of Pennsylvania
- Baylor University
- Harvard University
- IRCCS Multimedica
- Loyola University
- Stanford University
- University of South Carolina
- University of South Florida
- University of Sussex
- University of Tennessee
- Cardiff University
- Columbia University
- Medical University of South Carolina
- Department of Defense
- Ben Taub Hospital
- Tuberous Sclerosis Alliance
- The Tuberous Sclerosis Association
Organization Involved with Phase 1 Indications (3)